Kushner Peter J. 4
4 · Olema Pharmaceuticals, Inc. · Filed Nov 23, 2020
Insider Transaction Report
Form 4
Kushner Peter J.
Chief Scientific Officer
Transactions
- Conversion
Common Stock
2020-11-23+228,761→ 1,301,513 total - Conversion
Common Stock
2020-11-23+130,159→ 1,431,672 total - Conversion
Series A-1 Convertible Preferred Stock
2020-11-23−130,159→ 0 total→ Common Stock (130,159 underlying) - Conversion
Series A Convertible Preferred Stock
2020-11-23−228,761→ 0 total→ Common Stock (228,761 underlying)
Footnotes (1)
- [F1]The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock.